CHD vs REGN · P/E 32, rev $6.11B vs P/E 14, rev $14.34B
Church & Dwight Company Inc (CHD) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CHD currently screens at market cap $23.08B and trailing P/E 32.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CHD and REGN stock pages for the full models.
Not investment advice.